bioRxiv ScienceSearch

bioRxiv · 10.1101/172221

Climate change drives uncertain global shifts in potential distribution and seasonal risk of Aedes-transmitted viruses

Abstract

AbstractForecasting the impacts of climate change on Aedes-borne viruses--especially dengue, chikungunya, and Zika--is a key component of public health preparedness. We apply an empirically parameterized Bayesian transmission model of Aedes-borne viruses for the two vectors Aedes aegypti and Ae. albopictus as a function of temperature to predict cumulative monthly global transmission risk in current climates, and compare with projected risk in 2050 and 2080 based on general circulation models (GCMs). Our results show that if mosquito range shifts track optimal temperatures for transmission (26-29 {degrees}C), we can expect poleward shifts in Aedes-borne virus distributions. However, the differing thermal niches of the two vectors produce different patterns of shifts under climate change. More severe climate change scenarios produce proportionally worse population exposures from Ae. aegypti, but not from Ae. albopictus in the most extreme cases. Expanding risk of transmission from both mosquitoes will likely be a serious problem, even in the short term, for most of Europe; but significant reductions are also expected for Aedes albopictus, most noticeably in southeast Asia and west Africa. Within the next century, nearly a billion people are threatened with new exposure to both Aedes spp. in the worst-case scenario; but massive net losses in risk are noticeable for Ae. albopictus, especially in terms of year-round transmission, marking a global shift towards more seasonal risk across regions. Many other complicating factors (like mosquito range limits and viral evolution) exist, but overall our results indicate that while climate change will lead to both increased and new exposures to vector-borne disease, the most extreme increases in Ae. albopictus transmission are predicted to occur at intermediate climate change scenarios.\n\nAuthor SummaryThe established scientific consensus indicates that climate change will severely exacerbate the risk and burden of Aedes-transmitted viruses, including dengue, chikungunya, Zika, West Nile virus, and other significant threats to global health security. Here, we show that the story is more complicated, first and foremost due to differences between the more heat-tolerant Aedes aegypti and the more heat-limited Ae. albopictus. Almost a billion people could face their first exposure to viral transmission from either mosquito in the worst-case scenario, especially in Europe and high-elevation tropical and subtropical regions. On the other hand, while year-round transmission potential from Ae. aegypti is likely to expand (especially in south Asia and sub-Saharan Africa), Ae. albopictus loses significant ground in the tropics, marking a global shift towards seasonal risk as the tropics eventually become too hot for transmission by Ae. albopictus. Complete mitigation of climate change to a pre-industrial baseline could protect almost a billion people from arbovirus range expansions; but middle-of-the-road mitigation may actually produce the greatest expansion in the potential for viral transmission by Ae. albopictus. In any scenario, mitigating climate change also shifts the burden of both dengue and chikungunya (and potentially other Aedes transmitted viruses) from higher-income regions back onto the tropics, where transmission might otherwise start to be curbed by rising temperatures.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Ryan, S. J., Carlson, C. J., Mordecai, E. A., Johnson, L. R.. 2017-08-04. Climate change drives uncertain global shifts in potential distribution and seasonal risk of Aedes-transmitted viruses. https://doi.org/10.1101/172221

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Translating surveillance data into incidence estimates

Monitoring a population for a disease requires the hosts to be sampled and tested for the pathogen. This results in sampling series from which to estimate the disease incidence, i.e. the proportion of hosts infected. Existing estimation methods assume that disease incidence is not changing between monitoring rounds, resulting in underestimation of the disease incidence. In this paper we develop an incidence estimation model accounting for epidemic growth with monitoring rounds sampling varying incidence. We also show how to accommodate the asymptomatic period characteristic to most diseases. For practical use, we produce an approximation of the model, which is subsequently shown accurate for relevant epidemic and sampling parameters. Both the approximation and the full model are applied to stochastic spatial simulations of epidemics. The results prove their consistency for a very wide range of situations.

epidemiology

The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results

Primary Ciliary Dyskinesia (PCD) is a rare hereditary, multi-organ disease caused by defects in ciliary structure and function. It results in a wide range of clinical manifestations, most commonly in the upper and lower airways. Central data collection in national and international registries is essential to studying the epidemiology of rare diseases and filling in gaps in knowledge of diseases such as PCD. For this reason, the Swiss Primary Ciliary Dyskinesia Registry (CH-PCD) was founded in 2013 as a collaborative project between epidemiologists and adult and paediatric pulmonologists.\n\nThe registry records patients of any age, suffering from PCD, who are treated and resident in Switzerland. It collects information from patients identified through physicians, diagnostic facilities, and patient organisations. The registry dataset contains data on diagnostic evaluations, lung function, microbiology and imaging, symptoms, treatments, and hospitalizations.\n\nBy May 2018, CH-PCD has contacted 566 physicians of different specialties and identified 134 patients with PCD. At present this number represents an overall 1 in 63,000 prevalence of people diagnosed with PCD in Switzerland. Prevalence differs by age and region; it is highest in children and adults younger than 30 years, and in Espace Mittelland. The median age of patients in the registry is 25 years (range 5-73), and 49 patients have a definite PCD diagnosis based on recent international guidelines. Data from CH-PCD are contributed to international collaborative studies and the registry facilitates patient identification for nested studies.\n\nCH-PCD has proven to be a valuable research tool that already has highlighted weaknesses in PCD clinical practice in Switzerland. Development of centralised diagnostic and management centres and adherence to international guidelines are needed to improve diagnosis and management--particularly for adult PCD patients.

epidemiology

Perfect Counterfactuals for Epidemic Simulations

Simulation studies are often used to predict the expected impact of control measures in infectious disease outbreaks. Typically, two independent sets of simulations are conducted, one with the intervetnion, and one without, and epidemic sizes (or some related metric) are compared to estimate the effect of the intervention. Since it is possible that controlled epidemics are larger than uncontrolled ones if there is substantial stochastic variation between epidemics, uncertainty intervals from this approach can include a negative effect even for an effective intervention. To more precisely estimate the number of cases an intervention will prevent within a single epidemic, here we develop a single world approach to matching simulations of controlled epidemics to their exact uncontrolled counterfac-tual. Our method borrows concepts from percolation approaches prune out possible epidemic histories and create potential epidemic graph that can be realized to create perfectly matched controlled and uncontrolled epidemics. We present an implementation of this method for a common class of compartmental models, and its application in a simple SIR model. Results illustrate how, at the cost of some computation time, this method substantially narrows confidence intervals and avoids non-sensical inferences.

epidemiology